학술논문
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Document Type
Article
Author
Nguyen, Thuy P.; Do, Quyet; Phan, Lan T.; Dinh, Duc V.; Khong, Hiep; Hoang, Luong V.; Nguyen, Thuong V.; Pham, Hung N.; Chu, Men V.; Nguyen, Toan T.; Pham, Quang D.; Le, Tri M.; Trang, Tuyen N.T.; Dinh, Thanh T.; Vo, Thuong V.; Vu, Thao T.; Nguyen, Quynh B.P.; Phan, Vuong T.; Nguyen, Luong V.; Nguyen, Giang T.; Tran, Phong M.; Nghiem, Thuan D.; Tran, Tien V.; Nguyen, Tien G.; Tran, Tuynh Q.; Nguyen, Linh T.; Do, Anh T.; Nguyen, Dung D.; Ho, Son A.; Nguyen, Viet T.; Pham, Dung T.; Tran, Hieu B.; Vu, Son T.; Hoang, Su X.; Do, Trung M.; Ngoc, Hoan Vu; Nguyen, Xuan T.; Le, Giang Q.; Tran, Ton; Cao, Thang M.; Dao, Huy M.; Nguyen, Thao T.T.; Doan, Uyen Y; Le, Vy T.T.; Tran, Linh P.; Nguyen, Ngoc M.; Nguyen, Ngoc T.; Pham, Hang T.T.; Nguyen, Quan H.; Nguyen, Hieu T.; Nguyen, Hang L.K.; Tran, Vinh T.; Tran, Mai T.N.; Nguyen, Truc T.T.; Ha, Phat T.; Huynh, Hieu T.; Nguyen, Khanh D.; Thuan, Ung T.; Doan, Chung C.; Do, Si M.
Source
In The Lancet Regional Health - Western Pacific July 2022 24
Subject
Language
ISSN
2666-6065